Status:
COMPLETED
Evaluation of the Potential Impact of Computerized Antimicrobial Stewardship
Lead Sponsor:
China National Center for Cardiovascular Diseases
Conditions:
Antimicrobial Stewardship
Cardiovascular Surgeries
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This trial is an open-label, two-arm, cluster-randomized, controlled trial with cardiovascular surgical teams as the unit of randomization. Eligible teams with written consent are randomized to the in...
Detailed Description
The aim of the EPIC trial is to assess if a multicomponent computer-based system incorporated into the workflow can reduce days of therapy (DOT) per admission after cardiovascular surgeries in the int...
Eligibility Criteria
Inclusion
- Over 18 years of age;
- Receiving at least one open-chest cardiovascular surgery during the same admission.
Exclusion
- Intravenous or oral antimicrobial use within two weeks before surgery;
- Emergent/urgent surgery;
- Admitted for isolated stenting or heart transplantation or implantation of ventricular assist device or implantation of extracorporeal membrane oxygenation;
- Admitted for subacute bacterial endocarditis;
- Length of ICU stay over 48 hours.
Key Trial Info
Start Date :
November 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
2473 Patients enrolled
Trial Details
Trial ID
NCT04328090
Start Date
November 27 2020
End Date
June 30 2021
Last Update
March 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai Hospital
Beijing, Beijing Municipality, China, 100037